Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran

Abstract Background In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) provided a new guideline for hypertension prevention and management. We aimed to update the prevalence, awareness, control, and determinants of hypertension based on this guideline in Khuzestan provi...

Full description

Bibliographic Details
Main Authors: Fatemeh Sadeghi, Bahman Cheraghian, Zahra Mohammadi, Sadaf G. Sepanlou, Sahar Masoudi, Zahra Rahimi, Leila Danehchin, Yousef Paridar, Farhad Abolnezhadian, Mohammad Noori, Seyed Ali Mard, Ali Akbar Shayesteh, Hossein Poustchi
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Population Health Metrics
Subjects:
Online Access:https://doi.org/10.1186/s12963-021-00260-5
id doaj-52876a66c312424a9d4ad452275dadbc
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Fatemeh Sadeghi
Bahman Cheraghian
Zahra Mohammadi
Sadaf G. Sepanlou
Sahar Masoudi
Zahra Rahimi
Leila Danehchin
Yousef Paridar
Farhad Abolnezhadian
Mohammad Noori
Seyed Ali Mard
Ali Akbar Shayesteh
Hossein Poustchi
spellingShingle Fatemeh Sadeghi
Bahman Cheraghian
Zahra Mohammadi
Sadaf G. Sepanlou
Sahar Masoudi
Zahra Rahimi
Leila Danehchin
Yousef Paridar
Farhad Abolnezhadian
Mohammad Noori
Seyed Ali Mard
Ali Akbar Shayesteh
Hossein Poustchi
Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran
Population Health Metrics
Hypertension
Iran
2017 ACC/AHA hypertension guideline
JNC8 hypertension guideline
Risk factors
Prevalence
author_facet Fatemeh Sadeghi
Bahman Cheraghian
Zahra Mohammadi
Sadaf G. Sepanlou
Sahar Masoudi
Zahra Rahimi
Leila Danehchin
Yousef Paridar
Farhad Abolnezhadian
Mohammad Noori
Seyed Ali Mard
Ali Akbar Shayesteh
Hossein Poustchi
author_sort Fatemeh Sadeghi
title Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran
title_short Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran
title_full Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran
title_fullStr Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran
title_full_unstemmed Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran
title_sort impact of 2017 acc/aha guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of iran
publisher BMC
series Population Health Metrics
issn 1478-7954
publishDate 2021-05-01
description Abstract Background In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) provided a new guideline for hypertension prevention and management. We aimed to update the prevalence, awareness, control, and determinants of hypertension based on this guideline in Khuzestan province, southwest of Iran, and to estimate the number of people who are eligible for non-pharmacologic and pharmacologic intervention. Methods This population-based cross-sectional study was conducted in Khuzestan, a large province in the southwest of Iran. Comprehensive information about the potential relating factors of hypertension was collected, blood pressure was measured, and anthropometric measurements were obtained. Moreover, the dietary pattern was evaluated in 2830 individuals, using a qualitative food frequency questionnaire. Results Among 30,506 participants, 30,424 individuals aged 20–65 years were eligible for the study. In comparison with the previous guideline released by the Joint National Committee (JNC8), the prevalence of hypertension in Khuzestan dramatically increased from 15.81 to 42.85% after implementation of the ACC/AHA guideline, which was more dominant in the male population and the 45–54 age group. The sex and age adjustment of the hypertension prevalence was estimated to be 39.40%. The percentage of hypertension awareness, treatment, and control were 45.85%, 35.42%, and 59.63%, which dropped to 22.72%, 26.37%, and 28.94% after implementation of new guideline, respectively. Conclusions In the ACC/AHA guideline, a higher number of individuals with the pre-hypertension condition were shifted into the hypertension category and the level of awareness, treatment, and control were dramatically decreased, which highlight a great need to expand the public health infrastructure for further managing the substantial increased burden on healthcare system. However, further studies with population over 65 years are required to estimate the eligibility for antihypertensive treatment in this province after implementation of new guideline.
topic Hypertension
Iran
2017 ACC/AHA hypertension guideline
JNC8 hypertension guideline
Risk factors
Prevalence
url https://doi.org/10.1186/s12963-021-00260-5
work_keys_str_mv AT fatemehsadeghi impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT bahmancheraghian impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT zahramohammadi impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT sadafgsepanlou impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT saharmasoudi impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT zahrarahimi impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT leiladanehchin impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT yousefparidar impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT farhadabolnezhadian impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT mohammadnoori impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT seyedalimard impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT aliakbarshayesteh impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
AT hosseinpoustchi impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran
_version_ 1721420712031289344
spelling doaj-52876a66c312424a9d4ad452275dadbc2021-05-30T11:07:55ZengBMCPopulation Health Metrics1478-79542021-05-0119111110.1186/s12963-021-00260-5Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of IranFatemeh Sadeghi0Bahman Cheraghian1Zahra Mohammadi2Sadaf G. Sepanlou3Sahar Masoudi4Zahra Rahimi5Leila Danehchin6Yousef Paridar7Farhad Abolnezhadian8Mohammad Noori9Seyed Ali Mard10Ali Akbar Shayesteh11Hossein Poustchi12Department of Global Public Health, Karolinska InstituteAlimentary Tract Research Center, Imam Khomeini Hospital Clinical Research Development Unit, Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical SciencesLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical SciencesDigestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical SciencesLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical SciencesHearing Research Center, Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical SciencesBehbahan Faculty of Medical SciencesSchool of medicine, Dezful University of Medical SciencesShoshtar Faculty of Medical SciencesAbadan Faculty of Medical SciencesAlimentary Tract Research Center, Imam khomeini Hospital Clinical Research Development Unit, School of Medicine, Ahvaz Jundishapur University of Medical SciencesAlimentary Tract Research Center, Imam khomeini Hospital Clinical Research Development Unit, School of Medicine, Ahvaz Jundishapur University of Medical SciencesLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical SciencesAbstract Background In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) provided a new guideline for hypertension prevention and management. We aimed to update the prevalence, awareness, control, and determinants of hypertension based on this guideline in Khuzestan province, southwest of Iran, and to estimate the number of people who are eligible for non-pharmacologic and pharmacologic intervention. Methods This population-based cross-sectional study was conducted in Khuzestan, a large province in the southwest of Iran. Comprehensive information about the potential relating factors of hypertension was collected, blood pressure was measured, and anthropometric measurements were obtained. Moreover, the dietary pattern was evaluated in 2830 individuals, using a qualitative food frequency questionnaire. Results Among 30,506 participants, 30,424 individuals aged 20–65 years were eligible for the study. In comparison with the previous guideline released by the Joint National Committee (JNC8), the prevalence of hypertension in Khuzestan dramatically increased from 15.81 to 42.85% after implementation of the ACC/AHA guideline, which was more dominant in the male population and the 45–54 age group. The sex and age adjustment of the hypertension prevalence was estimated to be 39.40%. The percentage of hypertension awareness, treatment, and control were 45.85%, 35.42%, and 59.63%, which dropped to 22.72%, 26.37%, and 28.94% after implementation of new guideline, respectively. Conclusions In the ACC/AHA guideline, a higher number of individuals with the pre-hypertension condition were shifted into the hypertension category and the level of awareness, treatment, and control were dramatically decreased, which highlight a great need to expand the public health infrastructure for further managing the substantial increased burden on healthcare system. However, further studies with population over 65 years are required to estimate the eligibility for antihypertensive treatment in this province after implementation of new guideline.https://doi.org/10.1186/s12963-021-00260-5HypertensionIran2017 ACC/AHA hypertension guidelineJNC8 hypertension guidelineRisk factorsPrevalence